Trademark Overview
On Friday, July 10, 2026, a trademark application was filed for DYNO FRONTIERS with the United States Patent and Trademark Office. The USPTO has given the DYNO FRONTIERS trademark a serial number of 99932830. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 10, 2026. This trademark is owned by Dyno Therapeutics, Inc.. The DYNO FRONTIERS trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, gene therapy, gene delivery, and viral capsid technology; scientific research and development in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, viral capsid technology, genetic engineering, gene therapeutics, and research tools; biotechnology research services; research and development of new products in the field of gene therapeutics and research tools; providing a collaborative technology network for researchers and organizations in the fields of gene therapy, gene delivery, and viral capsid technology; facilitating scientific collaboration among gene therapy developers, manufacturers, and research organizations in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; providing access to proprietary capsid technologies for use in gene therapy and gene delivery research and development; data sharin...
Licensing of intellectual property, namely, licensing of gene therapy capsid technology to network participants; licensing of protein and nucleic acid sequences and methods of use in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; intellectual property licensing services in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; technology transfer services, namely, licensing and transfer of intellectual property in the fields of biotechnology, genetic medicine, gene therapy, gene delivery, and viral capsid technology; administration of licensing programs in the fields of gene therapy and viral capsid technologies
Association services, namely, promoting the interests of gene therapy developers, manufacturers, and research organizations in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; business networking services in the fields of genetic medicine, gene therapy, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; facilitating business connections and collaboration among organizations engaged in gene therapy development, gene delivery, viral capsid technology, and biomanufacturing for gene therapy and gene delivery applications; administration of a business network in the fields of genetic medicine, gene therapy, gene delivery, and viral capsid technology
